QIAGEN NV (QGEN)
QIAGEN Market Cap : 8.485B for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| InflaRx NV | 75.18M |
| CDT Equity, Inc. | 23.80M |
| LENZ Therapeutics, Inc. | 287.21M |
| Liminatus Pharma, Inc. | 8.392M |
| Oruka Therapeutics, Inc. | 3.019B |
Market Cap Related Metrics
| PE Ratio | 20.03 |
| PS Ratio | 4.072 |
| PEG Ratio | 0.0478 |
| Price to Book Value | 2.232 |
| Price to Free Cash Flow | 19.03 |
| Price | 41.19 |
| Earnings Yield | 4.99% |
| PEGY Ratio | 0.0478 |
| Operating PE Ratio | 16.32 |
| Normalized PE Ratio | 18.39 |